- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03162380
Occupational Stress and Bipolar Disorder
Assessment of Occupational Stress and Well-being in French Patients Suffering From Bipolar Disorder
Bipolar disorder is a mental disorder characterized by alternance of depressive and manic phases, separated by intercritical phases (euthymia). The majority of patients report occupation and professional difficulties. Sixty percent of bipolar patients are inactive . Indeed, according to the World Health Organisation, bipolar disorder is the second cause of days not worked.
Several factors are related to the lower professional functioning observed in bipolar patients: early age of onset, delay of diagnosis and treatment, recurrence of thymic episodes, residual symptoms and cognitive disorders during euthymia, side effects of mood stabilizers.
To our knowledge, no study has ever focused on well-being at work in French patients. However, suffering from a psychiatric disorder and the lack of support from colleagues and the hierarchy are risk factors for burnout, a growing health issue.
Patients with mental illness are often victims of stigmatization, which may involve the professional field. In addition, thymic recurrences may alter professional functioning of active patients: multiplication of work disruptions, conflicts with peers. Conversely work can be stressful, promoting thyic relapses. It is therefore essential to better understand the occupational stresses of active patients suffering from bipolar disorder in order to promote functional remission beyond clinical remission.
The aim of this study is to assess the level of stress and well-being at work in active French bipolar patients.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- Uhmontpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- out patients and inpatients in the Department of Emergency Psychiatry and Post Acute Care, CHU Montpellier, France
- to have completed the self-administered questionnaire on professional activity.
Exclusion Criteria:
- Deprived of liberty subject (by judicial or administrative decision)
- Protected by law (guardianship)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of occupational stress using a Likert scale
Time Frame: 1 day
|
level of occupational stress assessed at the patient visit will be collected, from 0 (none) to 10 (maximum possible occupational stress).
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presenteism during the last month using the Stanford Presenteeism Scale
Time Frame: 1 day
|
Presenteism during the last month assessed at the patient visit will be collected
|
1 day
|
Support of colleagues and superiors using the Karasek questionnaire.
Time Frame: 1 day
|
Support of colleagues and superiors assessed at the patient visit will be collected
|
1 day
|
Impact of work on the private sphere using the SWING scale (survey work-home interaction-Nijmegen)
Time Frame: 1 day
|
Impact of work on the private sphere assessed at the patient visit will be collected
|
1 day
|
Balance effort - reward in using the Siegrist questionaire
Time Frame: 1 day
|
Balance effort - reward assessed at the patient visit will be collected
|
1 day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL17_0138
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
Region StockholmKarolinska InstitutetRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II Disorder | Bipolar Affective Disorder; Remission in | Bipolar Affective Disorder, Currently Depressed, ModerateSweden
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Medical University of South CarolinaMilken InstituteCompletedBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Joshua RosenblatRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderCanada
-
Mayo ClinicCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Joshua RosenblatRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderCanada
-
Myriad Genetic Laboratories, Inc.University of MinnesotaCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
Clinical Trials on Date collection
-
Medical University of ViennaUnknownAdvanced Non-small-cell Lung CancerAustria
-
University Hospital, MontpellierCHU Clermont Ferrand - Dpt Pharmacologie Médicale (Pr Nicolas AUTHIER)Completed
-
State University of New York at BuffaloEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Northeastern UniversityRhode Island HospitalCompleted
-
Applied Science & Performance InstituteStanford UniversityCompletedMental Health Wellness 1 | Depression, Anxiety | Psychological Stress | Psychological | Mental Stress | Mental DepressionUnited States
-
Stanford UniversityActive, not recruitingResilience, Psychological | Wearable Devices | Psychological Wellness | Personal and Professional Fulfilment | MultiomicsUnited States
-
Selcuk UniversityCompletedLabor | Augmentation | Induction | Stimulation, SelfTurkey
-
Second Affiliated Hospital of Wenzhou Medical UniversityUnknownThe Relationship Between Pre-pregnancy BMI and Weight Gain and Outcomes in Women With Twin PregnancyTwin Pregnancy; Body Mass Index; Weight Gain; Pregnancy OutcomeChina
-
Newcastle UniversityCompleted
-
University Hospital, MontpellierUnknown